6.7-kbp deletion in LILRA3 (ILT6) gene is associated with later onset of the multiple sclerosis in a Polish population

Human Immunology

Volumn 74, Issue 3, 2013, Pages 353-357

  Wiśniewski, Andrzej ^a   Wagner, Marta ^a   Nowak, Izabela ^a   Bilińska, Małgorzata ^b   Pokryszko Dragan, Anna ^b   Jasek, Monika ^a   Kuśnierczyk, Piotr ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; HLA DRB1 ANTIGEN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE DELETION; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LEUKOCYTE IMMUNOGLOBULIN LIKE SUBFAMILY A MEMBER 3 GENE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MUTATIONAL ANALYSIS; ONSET AGE; PHENOTYPE; POLAND; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-DRB1 CHAINS; HUMANS; LINEAR MODELS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLAND; RECEPTORS, IMMUNOLOGIC; SEQUENCE DELETION; YOUNG ADULT;

EID: 84873746576     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.12.006     Document Type: Article

References (42)

1. Sadovnik A.D., Armstrong H., Rice G.P., Bulman D., Hashimoto L., Paty D.W., et al. A population-based study of multiple sclerosis in twins: update. Ann Neurol 1993, 33:281-285.
2. Mumford C.J., Wood N.W., Kellar-Wood H., Thorpe J.W., Miller D.H., Compston D.A. The British Isles survey of multiple sclerosis in twins. Neurology 1994, 44(1):11-15.
3. Ebers G.C., Sadovnick A.D., Risch N.J. A genomic basis for familial aggregation in multiple sclerosis. The canadian collaborative study group. Nature 1995, 377:150-151.
4. Casetta I., Granieri E. Prognosis of multiple sclerosis: environmental factors. Neurol Sci 2000, 21:S839.
5. Ebbers G.C. Environmental factors and multiple sclerosis. Lancet Neurol 2008, 7(3):268-277.
6. Fogdell A., Olerup O., Fredrikson S., Vrethem M., Hillert J. Linkage analysis of HLA class II genes in swedish multiplex families with multiple sclerosis. Neurology 1997, 48:758-762.
7. Stewart G.J., Teutsch S.M., Castle M., Heard R.N., Bennetts B.H. HLA-DR,-DQA1 and -DQB1 associations in Australian multiple sclerosis patients. Eur J Immunogenet 1997, 24:81-92.
8. Haines J.L., Terwedow H.A., Burgess K., Pericak-Vance M.A., Rimmler J.B., Martin E.R., et al. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. Hum Mol Genet 1998, 7:1229-1234.
9. Multiple Sclerosis Genetics Group A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat Genet 1996, 13:469-476.
10. Sawcer S., Jones H.B., Feakes R., Gray J., Smaldon N., Chataway J., et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 1996, 13:464-468.
11. Haines J.L., Bradford Y., Garcia M.E., Reed A.D., Neumeister E., Pericak-Vance M.A., et al. Multiple susceptibility loci for multiple sclerosis. Hum Mol Genet 2002, 11:2251-2256.
12. Pericak-Vance M.A., Rimmler J.B., Haines J.L., Garcia M.E., Oksenberg J.R., Barcellos L.F., et al. Investigation of seven proposed regions of linkage in multiple sclerosis: an American and French collaborative study. Neurogenetics 2004, 5:45-48.
13. Bonetti A., Koivisto K., Pirttila T., Elovaara I., Reunanen M., Laaksonen M., et al. A follow-up study of chromosome 19q13 in multiple sclerosis susceptibility. J Neuroimmunol 2009, 208:119-124.
14. Barcellos L.F., Thomson G., Carrington M., Schafer J., Begovich A.B., Lin P., et al. Chromosome 19 single-locus and mutilocus haplotype associations with multiple sclerosis. Evidence of a new susceptibility locus in caucasian and Chinese patients. JAMA 1997, 278(15):1256-1261.
15. Koch S., Goedde R., Nigmatova V., Epplen J.T., Muller N., de Seze J., et al. Association of multiple sclerosis with ILT6 deficiency. Genes Immun 2005, 6:445-447.
16. Ordonez D., Sanchez A.J., Martinez-Rodriguez J.E., Cisneros E., Ramil E., Romo N., et al. Multiple sclerosis associates with LILRA3 deletion in Spanish patients. Genes Immun 2009, 10(6):579-585.
17. Cosman D., Fanger N., Borges L., Kubin M., Chin W., Peterson L., et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 1997, 7:273-282.
18. Torkar M., Haude A., Milne S., Beck S., Trowsdale J., Wilson M.J. Arrangement of the ILT gene cluster: a common null allele of the ILT6 gene results from a 6,7-kbp deletion. Eur J Immunol 2000, 30:3655-3662.
19. Anderson K.J., Allen R.L. Regulation of T-cell immunity by leucocyte immunoglobulin-like receptors: innate immune receptors for self on antigen-presenting cells. Immunology 2009, 127(1):8-17.
20. Borges L., Hsu M.L., Fanger N., Kubin M., Cosman D. A family of human lymphoid and myeloid ig-like receptors, same of which bind to MHC class I molecules. J Immunol 1997, 159:5192-5196.
21. Samaridis J., Colonna M. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structure evidence for new stimulatory and inhibitory pathways. Eur J Immunol 1997, 27:660-665.
22. Saverino D., Fabbi M., Ghiotto F., Merlo A., Bruno S., Zarcone D., et al. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions. J Immunol 2000, 165:3742-3755.
23. Arm J.P., Nwankwo C., Austen K.F. Molecular identification of a novel family of human ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor. J Immunol 1997, 159(5):2342-2349.
24. Ryu M., Chen Y., Qi J., Liu J., Fan Z., Nam G., et al. LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidence. PloS One 2011, 6(4):e19245.
25. An H., Chandra V., Piraino B., Borges L., Geczy C., McNeil H.P., et al. Soluble LILRA3, a potential natural antiinflammatory protein, is increased in patients with rheumatoid arthritis and is tightly regulated by interleukin 10, tumor necrosis factor-alpha, and interferon-gamma. J Rheumatol 2010, 37(8):1596-1606.
26. WiŚniewski A., Łuszczek W., Mańczak M., Jasek M., Kubicka W., Cislo M., et al. Distribution of LILRA3 (ILT6/LIR4) deletion in psoriatic patients and healthy controls. Hum Immunol 2003, 64:458-461.
27. Norman P.J., Cook M.A., Carey B.S., Carrington C.V., Verity D.H., Hameed K., et al. SNP haplotypes and allele frequencies show evidence for disruptive and balancing selection in the human leukocyte receptor complex. Immunogenetics 2004, 56:225-237.
28. Hirayasu K., Ohashi J., Kashiwase K., Takanashi M., Satake M., Tokunaga K., et al. Long-term persistence of both functional and non-functional alleles suggests balancing selection. Hum Genet 2006, 119:436-443.
29. Hirayasu K., Ohashi J., Tanaka H., Kashiwase K., Ogawa A., Takanashi, et al. Evidence for natural selection on leukocyte immunoglobulin-like receptors for HLA class I in Northeast Asians. Am J Hum Genet 2008, 82(5):1075-1083.
30. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50(1):121-127.
31. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status score (EDSS). Neurology 1983, 33:1444-1452.
32. Roxburgh R.H., Seaman S.R., Masterman T., Hensiek A.E., Sawcer S.J., Vukusic S., et al. Multiple sclerosis severity score: using disability and disease duration to rate disease severity. Neurology 2005, 64(7):1144-1151.
33. Wilson M.J., Torkar M., Haude A., Milne S., Jones T., Sheer D., et al. Plasticity in the organization and sequences of human KIR/ILT gene families. PNAS 2000, 97(9):4778-4783.
34. *1501 allele. Tissue Antigens 2008, 72:401-403.
35. Kabalak G., Dobberstein S.B., Matthias T., Reuter S., The Y.H., Dörner T., et al. Association of immunoglobulin-like transcript 6 deficiency with Sjögren's syndrome. Arthritis Rheum 2009, 60(10):2923-2925.
36. Moodie S.J., Norman P.J., King A.L., Fraser J.S., Curtis D., Ellis H.J., et al. Analysis of candidate genes on chromosome 19 in coeliac disease: an association study of the KIR and LILR gene clusters. Eur J Immunogenet 2002, 29(4):287-291.
37. Jones D.C., Kosmoliaptsis V., Apps R., Lapaque N., Smith I., Kono A., et al. HLA class I allelic sequence and conformation regulate leukocyte ig-like receptor binding. J Immunol 2011, 186(5):2990-2997.
38. Shiroishi M., Kuroki K., Rasubala L., Tsumoto K., Kumagai I., Kurimoto E., et al. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). PNAS 2006, 103(44):16412-16417.
39. Thomas R., Matthias T., Witte T. Leukocyte immunoglobulin-like receptors as new players in autoimmunity. Clinic Rev Allerg Immunol 2010, 38:159-162.
40. Schmidt H., Williamson D., Ashley-Koch A. HLA-DR15 haplotype and multiple sclerosis: a HuGE review. Am J Epidemiol 2007, 165(10):1097-1109.
41. Schmidt A.H., Solloch U.V., Pingel J., Baier D., Böhme I., Dubicka K., et al. High-resolution human leukocyte antigen allele and haplotype frequencies of the Polish population based on 20,653 stem cell donors. Hum Immunol 2011, 72(7):558-565.
42. Nowak J., Mika-Witkowska R., Polak M., Zajko M., Rogatko-KoroŚ M., Graczyk-Pol E., et al. Allele and extended haplotype polymorphism of HLA-A, -C, -B, -DRB1 and -DQB1 loci in Polish population and genetic affinities to other populations. Tissue Antigens 2008, 71(3):193-205.